Cargando…
Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008329/ https://www.ncbi.nlm.nih.gov/pubmed/33785883 http://dx.doi.org/10.1038/s41575-021-00445-1 |
| _version_ | 1783672672871251968 |
|---|---|
| author | Ray, Katrina |
| author_facet | Ray, Katrina |
| author_sort | Ray, Katrina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8008329 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80083292021-03-30 Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD Ray, Katrina Nat Rev Gastroenterol Hepatol In Brief Nature Publishing Group UK 2021-03-30 2021 /pmc/articles/PMC8008329/ /pubmed/33785883 http://dx.doi.org/10.1038/s41575-021-00445-1 Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | In Brief Ray, Katrina Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD |
| title | Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD |
| title_full | Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD |
| title_fullStr | Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD |
| title_full_unstemmed | Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD |
| title_short | Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD |
| title_sort | antibody responses to sars-cov-2 infection are attenuated in infliximab-treated patients with ibd |
| topic | In Brief |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008329/ https://www.ncbi.nlm.nih.gov/pubmed/33785883 http://dx.doi.org/10.1038/s41575-021-00445-1 |
| work_keys_str_mv | AT raykatrina antibodyresponsestosarscov2infectionareattenuatedininfliximabtreatedpatientswithibd |